EMV Capital plc (NTK1)

Overview

NetScientific plc is a venture capital firm established in 2008 and located in London, United Kingdom. The firm is specialized in seed, growth capital, and early to mid-stage investments, primarily focusing its efforts on advancing sustainability, life science, technology, and particularly transformative biomedical and healthcare technologies. It aims at investment opportunities within the digital health, diagnostics, and therapeutics sectors, highlighting a keen interest in innovations that significantly enhance the health and well-being of individuals suffering from chronic diseases. NetScientific plc targets companies in European developed markets, the United Kingdom, and the United States, with typical investment amounts up to £15 million ($20.32 million), and in certain cases considering larger sums. The firm actively seeks to secure a controlling interest in its principal subsidiaries and endeavors to invest through its robust balance sheet, marking a strategic and impactful presence in the venture capital landscape.

Products and Services

• Seed and Growth Capital Investments

Providing financial support for startups and early-stage companies. NetScientific plc facilitates the growth of promising ventures within the realms of technology, sustainability, and healthcare, leveraging its capital and expertise to nurture innovative solutions from inception through development.

• Early and Mid Stage Investments

Focusing on more established entities that are poised for significant growth. By investing in these companies, NetScientific plc aims to accelerate their development within the digital health, diagnostics, and therapeutics sectors, ensuring that groundbreaking healthcare solutions reach the market more swiftly.

• Transformative Biomedical and Healthcare Technologies

Dedicated investments in cutting-edge solutions that promise to revolutionize patient care. This includes digital health innovations such as data analytics, wearable technologies, and advanced medical devices, all designed to enhance diagnostic accuracy, treatment efficacy, and overall patient outcomes in chronic disease management.

• Global Investment Focus

While NetScientific plc extends its investment reach to European developed markets and the United States, it maintains a particular interest in backing companies located in the United Kingdom, reflecting a strategy to reinforce its stronghold within pioneering sectors of the global market.

• Controlling Interest Investment Approach

By preferring to hold a controlling interest in all principal subsidiaries, NetScientific plc ensures a degree of influence over the strategic direction of its investments, enabling a hands-on approach to nurturing businesses towards achieving their full potential.